Opportunity
DIBBS #SPE2DP-26-T-4320
DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 3 bottles)
Posted
July 28, 2026
Respond By
August 03, 2026
Identifier
SPE2DP-26-T-4320
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is seeking to procure Moxifloxacin Hydrochloride Tablets for medical use. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - OEMs (Original Equipment Manufacturers): - TEVA Pharmaceuticals USA, Inc. - Rising Pharma Holdings, Inc. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - National Stock Number (NSN): 6505-01-503-4772 - Quantity: 3 bottles - TEVA Pharmaceuticals USA, Inc. (Part Number: NDC00093-7387-56) - Rising Pharma Holdings, Inc. (Part Number: NDC57237-0156-30) - Notable Requirements: - Product must comply with FDA regulations - Packaging and labeling must meet Medical Marking Standard No. 1A - Delivery required within 20 days, FOB destination - Storage at controlled room temperature and avoidance of high humidity - Only approved sources (TEVA and Rising Pharma) are accepted
Description
MOXIFLOXACIN HYDROCHLO (QTY: 3, NSN: 6505-01-503-4772, Purchase Request: 7017626093) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.